GraniteShares Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-674
Closed -$299K 111
2023
Q2
$299K Sell
674
-32
-5% -$14.8K 0.27% 84
2023
Q1
$325K Sell
706
-57
-7% -$27.1K 0.29% 91
2022
Q4
$391K Sell
763
-104
-12% -$52.8K 0.32% 106
2022
Q3
$393K Sell
867
-77
-8% -$36.8K 0.32% 100
2022
Q2
$455K Sell
944
-137
-13% -$67.8K 0.33% 96
2022
Q1
$531K Sell
1,081
-4
-0.4% -$1.83K 0.29% 106
2021
Q4
$502K Buy
+1,085
New +$456K 0.23% 117

Other funds holding ELV

GraniteShares Advisors's ELV Position: Q3 2023 in Review

GraniteShares Advisors sold out of Elevance Health (ELV) in Q3 2023, closing a stake of 674 shares — an estimated $299K sold.

GraniteShares Advisors first reported a position in ELV in Q4 2021 and held it in 7 quarters. The position peaked at $531K in Q1 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • GraniteShares Advisors reported no remaining Elevance Health position as of Q3 2023 after selling out during the quarter.
  • GraniteShares Advisors sold 674 Elevance Health shares in Q3 2023, an estimated $299K.
  • GraniteShares Advisors first reported a position in Elevance Health in Q4 2021 and held it in 7 quarters.
  • GraniteShares Advisors's Elevance Health position peaked at $531K in Q1 2022.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on GraniteShares Advisors's 13F filing for Q3 2023, filed 31 Oct 2023.